Tharimmune, Inc. | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
Tharimmune, Inc.

BRIEF

published on 10/30/2024 at 13:05, 4 days ago

Tharimmune obtient les commentaires de l'EMA pour le TH104 dans le prurit chronique

Tharimmune Traitement De La CBP Commentaires De L'EMA Programme Clinique TH104 Prurit Chronique
BRIEF

published on 10/30/2024 at 13:05, 4 days ago

Tharimmune Secures EMA Feedback for TH104 in Chronic Pruritus

Chronic Pruritus Tharimmune PBC Treatment EMA Feedback TH104 Clinical Program
PRESS RELEASE

published on 10/30/2024 at 13:00, 4 days ago

Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis
Tharimmune, Inc. receives positive feedback from EMA on Phase 2 trial plans for TH104, a clinical candidate for pruritus in PBC, a rare liver disease

Tharimmune Inc. Phase 2 Trial PBC Pruritus European Medicines Agency
BRIEF

published on 10/28/2024 at 14:05, 5 days 23 hours ago

Tharimmune annonce des résultats positifs de phase 1 pour le TH104 lors de la réunion de l'ACG

TH104 Essai De Phase 1 Maladie Chronique Du Foie Prurit Sécurité Clinique
BRIEF

published on 10/28/2024 at 14:05, 5 days 23 hours ago

Tharimmune Reports Positive Phase 1 Results for TH104 at ACG Meeting

TH104 Phase 1 Trial Pruritus Chronic Liver Disease Clinical Safety
PRESS RELEASE

published on 10/28/2024 at 14:00, 5 days 23 hours ago

Tharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific Meeting
Tharimmune presents positive Phase 1 data for TH104 in treating pruritus in chronic liver disease patients at ACG 2024. No opioid withdrawal effects observed, supporting safety profile

TH104 Tharimmune Pruritus Chronic Liver Disease Phase 1 Data
BRIEF

published on 10/25/2024 at 14:05, 8 days 23 hours ago

Tharimmune présentera ses principales conclusions lors de prochaines conférences

Biotechnologie Conference Tharimmune Thérapeutique Immunologie
BRIEF

published on 10/25/2024 at 14:05, 8 days 23 hours ago

Tharimmune to Present Key Findings at Upcoming Conferences

Biotechnology Conference Therapeutics Tharimmune Immunology
PRESS RELEASE

published on 10/25/2024 at 14:00, 8 days 23 hours ago

Tharimmune Announces Upcoming Conference Presentations
Tharimmune, Inc. to present new results from Phase 1 trial of TH104 at ACG 2024 Annual Scientific Meeting. CEO to speak at 2024 ThinkEquity Conference in NY. Webcast available

Tharimmune Inc. Phase 1 Trial Clinical-stage Biotechnology ACG 2024 ThinkEquity Conference
BRIEF

published on 07/22/2024 at 14:35, 3 months 11 days ago

Tharimmune Appoints Prof. David Jones of Newcastle University to its Scientific Advisory Board

Scientific Advisory Board TH104 Tharimmune David Jones Autoimmune Liver Disease

1 2 ... 4

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 27 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 57 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours 2 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 42 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 20 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE